Home Cart 0 Sign in  

[ CAS No. 56619-93-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 56619-93-3
Chemical Structure| 56619-93-3
Structure of 56619-93-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 56619-93-3 ]

Related Doc. of [ 56619-93-3 ]

Alternatived Products of [ 56619-93-3 ]

Product Details of [ 56619-93-3 ]

CAS No. :56619-93-3 MDL No. :MFCD00662896
Formula : C12H17NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :DAFHCFQPQMYDFI-UHFFFAOYSA-N
M.W : 207.27 Pubchem ID :546358
Synonyms :

Calculated chemistry of [ 56619-93-3 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.42
Num. rotatable bonds : 4
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 61.41
TPSA : 38.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.65 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.58
Log Po/w (XLOGP3) : 2.7
Log Po/w (WLOGP) : 2.49
Log Po/w (MLOGP) : 2.11
Log Po/w (SILICOS-IT) : 2.16
Consensus Log Po/w : 2.41

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.86
Solubility : 0.287 mg/ml ; 0.00139 mol/l
Class : Soluble
Log S (Ali) : -3.16
Solubility : 0.144 mg/ml ; 0.000695 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.74
Solubility : 0.0375 mg/ml ; 0.000181 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.56

Safety of [ 56619-93-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 56619-93-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 56619-93-3 ]
  • Downstream synthetic route of [ 56619-93-3 ]

[ 56619-93-3 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 56619-93-3 ]
  • [ 6931-19-7 ]
Reference: [1] Synthesis, 1998, # 8, p. 1176 - 1180
  • 2
  • [ 56619-93-3 ]
  • [ 1611-78-5 ]
  • [ 6931-19-7 ]
Reference: [1] Journal of Organic Chemistry, 1991, vol. 56, # 26, p. 7288 - 7291
  • 3
  • [ 56619-93-3 ]
  • [ 927-63-9 ]
  • [ 6931-19-7 ]
Reference: [1] Journal of Organic Chemistry, 1991, vol. 56, # 26, p. 7288 - 7291
  • 4
  • [ 56619-93-3 ]
  • [ 112970-44-2 ]
Reference: [1] Journal of the American Chemical Society, 2004, vol. 126, # 4, p. 1150 - 1160
  • 5
  • [ 3282-30-2 ]
  • [ 536-90-3 ]
  • [ 56619-93-3 ]
YieldReaction ConditionsOperation in experiment
99.5% With sodium carbonate monohydrate In water; ethyl acetate at 0℃; for 1 h; Inert atmosphere Synthesis of N-(3-methoxyphenyl)pivalamide (1a)
Under the argon atmosphere, pivaloyl chloride (25.0 mL, 205 mmol, commercial product) was slowly dropped at 0°C into a mixed solution including m-anisidine (21.9 mL, 195 mmol, commercial product), ethyl acetate (EtOAc) (300 mL) of sodium carbonate monohydrate (62.0 g, 500 mmol, commercial product), and purified water (860 mL).
After the mixture was stirred at 0°C for 1 hour, the organic layer was separated and the aqueous layer was extracted with ethyl acetate (EtOAc).
The combined organic layer was dried over sodium sulfate and filtered.
The filtrate was concentrated under reduced pressure.
The residue was recrystallized with ethyl acetate (EtOAc), and thus N-(3-methoxyphenyl)pivalamide (compound 1a) (40.2 g, 194 mmol, 99.5percent) was obtained as a colorless solid.
TLC Rf = 0.50 (n-hexane/EtOAc = 6/1)
99.5% With sodium carbonate monohydrate In water; ethyl acetate at 0℃; for 1 h; Inert atmosphere Synthesis of N-(3-methoxyphenyl)pivalamide (1a)
Under the argon atmosphere, pivaloyl chloride (25.0 mL, 205 mmol, commercial product) was slowly dropped at 0° C. into a mixed solution including m-anisidine (21.9 mL, 195 mmol, commercial product), ethyl acetate (EtOAc) (300 mL) of sodium carbonate monohydrate (62.0 g, 500 mmol, commercial product), and purified water (860 mL).
After the mixture was stirred at 0° C. for 1 hour, the organic layer was separated and the aqueous layer was extracted with ethyl acetate (EtOAc).
The combined organic layer was dried over sodium sulfate and filtered.
The filtrate was concentrated under reduced pressure.
The residue was recrystallized with ethyl acetate (EtOAc), and thus N-(3-methoxyphenyl)pivalamide (compound 1a) (40.2 g, 194 mmol, 99.5percent) was obtained as a colorless solid.
TLC Rf=0.50 (n-hexane/EtOAc=6/1)
97% With triethylamine In dichloromethane at 0 - 22℃; for 14 h; Triethylamine (5. 0 mL, 35.6 mmol) was added to a flask containing the amine H1 (2.0 mL, 17.8 MMOL) and dichloromethane (100 mL) under an atmosphere of nitrogen. The contents were cooled in an ice bath and trimethylacetylchloride (3.3 mL, 26.7 MMOL) was added dropwise. The reaction was allowed to warm slowly to R. T. and stirred for 14 h. at this temperature. The reaction was quenched with NAHC03SATURATED SOLUTION and extracted with EtOAc. The combined organic layers were dried, filtered and concentrated followed by flash column chromatography (4: 1 to 1: 1 hexane: EtOAc) to yield the desired product H2 as an off-white solid (3.7 g, 97 percent yield).
94% at 0℃; for 12 h; To a solution of m-Anisidine (123.2 g, 1 mol), pyridine (161.1 mL, 2 mol) and 4-dimethylaminopyridine (1.2 g, 10 mmol) in dry CH2Cl2 (300 mL) was added pivaloyl chloride (135.4 mL, 1.1 mol) dropwise at 0 °C. The resulting mixture was stirred for 12 hours at that temperature, and poured into ice-cooled 1 M HCl. The organic layer was separated and the aqueous phase was extractedwith CH2Cl2. The combined organic extracts were washed with 1 M HCl and brine, and dried over Na2SO4. The solvents wereremoved under reduced pressure, pure white 3-Methoxy-N-pivaloylaniline was obtained after crystallization from hexanes. Colorless solid 194 g, mp 132-133 °C (Lit1: 132-133 °C), 94percent yield. 1H NMR (300 MHz, CDCl3): δ = 7.39 (s, 1H), 7.32 (bs, 1H), 7.20(t, J = 8.1 Hz, 1H), 6.94 (t, J = 8.1 Hz, 1H), 6.66 (dd, J = 1.5, 8.1 Hz, 1H), 3.80 (s, 3H), 1.31 (s, 9H); LRMS (ESI) for [C12H17NO2 + H]+ :208.1; for [C12H17NO2 + Na]+: 230.1.

Reference: [1] Journal of the American Chemical Society, 2004, vol. 126, # 4, p. 1150 - 1160
[2] Patent: EP2881397, 2015, A1, . Location in patent: Paragraph 0053; 0054; 0055
[3] Patent: US2016/303089, 2016, A1, . Location in patent: Paragraph 0161; 0162; 0163; 0164
[4] Patent: WO2004/103996, 2004, A1, . Location in patent: Page 51
[5] Synlett, 2011, # 7, p. 1018 - 1022
[6] Journal of Heterocyclic Chemistry, 1980, vol. 17, # 9, p. 1333 - 1335
[7] Synthesis (Germany), 2017, vol. 49, # 1, p. 181 - 187
[8] Angewandte Chemie - International Edition, 2008, vol. 47, # 5, p. 888 - 890
[9] Synthesis (Germany), 2014, vol. 46, # 13, p. 1773 - 1778
[10] Journal of Organic Chemistry, 1988, vol. 53, # 12, p. 2844 - 2847
[11] Journal of Organic Chemistry, 2018, vol. 83, # 8, p. 4812 - 4823
[12] European Journal of Medicinal Chemistry, 2010, vol. 45, # 7, p. 2726 - 2732
[13] Journal of Fluorine Chemistry, 2010, vol. 131, # 7, p. 800 - 804
[14] Journal of the American Chemical Society, 2010, vol. 132, # 37, p. 12862 - 12864
[15] Tetrahedron Letters, 2011, vol. 52, # 36, p. 4681 - 4685
[16] Chemical Communications, 2014, vol. 50, # 94, p. 14862 - 14865
[17] Angewandte Chemie - International Edition, 2015, vol. 54, # 49, p. 14866 - 14870[18] Angew. Chem., 2015, vol. 127, # 49, p. 15079 - 15083,5
[19] Patent: WO2016/34512, 2016, A1, . Location in patent: Page/Page column 72
[20] Green Chemistry, 2017, vol. 19, # 9, p. 2111 - 2117
[21] Organic Letters, 2018, vol. 20, # 3, p. 676 - 679
[22] Angewandte Chemie - International Edition, 2018, vol. 57, # 29, p. 9108 - 9112[23] Angew. Chem., 2018, vol. 130, p. 9246 - 9250,5
  • 6
  • [ 75151-82-5 ]
  • [ 74-88-4 ]
  • [ 56619-93-3 ]
YieldReaction ConditionsOperation in experiment
91% With potassium carbonate In acetone for 3 h; Heating / reflux Synthesis of N-(3-methoxyphenyl)pivalamide
Into a 1000 mL round-bottom flask, was placed a solution of N-(3-hydroxyphenyl)pivalamide (13.4 g, 69.43 mmol, 1.00 equiv) in acetone (500 mL).
To this was added K2CO3 (28.5 g, 206.52 mmol, 3.00 equiv).
To the mixture was added MeI (39.4 g, 277.46 mmol, 4.00 equiv).
The resulting solution was allowed to react, with stirring, for 3 h while the temperature was maintained at reflux in a bath of oil.
The reaction progress was monitored by TLC (EtOAc/PE=1:2).
A filtration was performed.
The filtrate was concentrated by evaporation under vacuum using a rotary evaporator.
The resulting mixture was washed with hexane.
A filtration was performed.
This resulted in 13.9 g (91percent) of N-(3-methoxyphenyl)pivalamide as a white solid.
91% With potassium carbonate In acetone for 3 h; Heating / reflux Methyl iodide (277 mmol) was added to a suspension of N-(3-hydroxyphenyl)pivalamide (69.4 mmol) and potassium carbonate (207 mmol) in acetone (500 mL) and the reaction mixture was heated at reflux for 3 h. The insoluble solids were removed by filtration and the filtrate was concentrated. The residue was extracted with hexane (3 x 300 mL) and the combined extracts were concentrated to provide N-(3-methoxyphenyl)pivalamide in 91percent yield as a white solid.
91% With potassium carbonate In acetone for 3 h; Heating / reflux Synthesis of N-(3-methoxyphenyl)pivalamide
Into a 1000 mL round-bottom flask, was placed a solution of N-(3-hydroxyphenyl)pivalamide (13.4 g, 69.43 mmol, 1.00 equiv) in acetone (500 mL).
To this was added K2CO3 (28.5 g, 206.52 mmol, 3.00 equiv).
To the mixture was added MeI (39.4 g, 277.46 mmol, 4.00 equiv).
The resulting solution was allowed to react, with stirring, for 3 h while the temperature was maintained at reflux in a bath of oil.
The reaction progress was monitored by TLC (EtOAc/PE=1.2).
A filtration was performed.
The filtrate was concentrated by evaporation under vacuum using a rotary evaporator.
The resulting mixture was washed with hexane.
A filtration was performed.
This resulted in 13.9 g (91percent) of N-(3-methoxyphenyl)pivalamide as a white solid.
91% With potassium carbonate In acetone for 3 h; Reflux 2. Synthesis of N-(3-methoxyphenyl)pivalamide; Methyl iodide (277 mmol) was added to a suspension of N-(3-hydroxyphenyl)pivalamide (69.4 mmol) and potassium carbonate (207 mmol) in acetone (500 mL) and the reaction mixture was heated at reflux for 3 h. The insoluble solids were removed by filtration and the filtrate was concentrated. The residue was extracted with hexane (3.x.300 mL) and the combined extracts were concentrated to provide N-(3-methoxyphenyl)pivalamide in 91percent yield as a white solid.
91% With potassium carbonate In acetone for 3 h; Reflux 2. Synthesis of 7V-(3-methoxyphenyl)pivalamide.Methyl iodide (277 mmol) was added to a suspension of 7V-(3 -hydro xyphenyl)pivalamide (69.4 mmol) and potassium carbonate (207 mmol) in acetone (500 mL) and the reaction mixture was heated at reflux for 3 h. The insoluble solids were removed by filtration and the filtrate was concentrated. The residue was extracted with hexane (3 x 300 mL) and the combined extracts were concentrated to provide 7V-(3-methoxyphenyl)pivalamide in 91percent yield as a white solid.
91% With potassium carbonate In acetone for 3 h; Reflux Methyl iodide (277 mmol) was added to a suspension of N-(3-hydroxyphenyl)pivalamide (69.4 mmol) and potassium carbonate (207 mmol) in acetone (500 mL) and the reaction mixture was heated at reflux for 3 h. The insoluble solids were removed by filtration and the filtrate was concentrated. The residue was extracted with hexane (3.x.300 mL) and the combined extracts were concentrated to provide N-(3-methoxyphenyl)pivalamide in 91percent yield as a white solid
91% With potassium carbonate In acetone for 3 h; Reflux 2. Synthesis of 7V-(3-methoxyphenyl)pivalamide. Methyl iodide (277 mmol) was added to a suspension of 7V-(3-hydroxyphenyl)pivalamide(69.4 mmol) and potassium carbonate (207 mmol) in acetone (500 mL) and the reaction mixture was heated at reflux for 3 h. The insoluble solids were removed by filtration and the filtrate was concentrated. The residue was extracted with hexane (3 x 300 mL) and the combined extracts were concentrated to provide N-(3-methoxyphenyl)pivalamide in 91percent yield as a white solid. 3. Synthesis of iV-(2-(2-hvdroxyethv0-3-methoxyphenyl)pivalamide.
91% With potassium carbonate In acetone for 3 h; Reflux Methyl iodide (277 mmol) was added to a suspension of N-(3-hydroxyphenyl)pivalamide (69.4 mmol) and potassium carbonate (207 mmol) in acetone (500 mL) and the reaction mixture was heated at reflux for 3 h.
The insoluble solids were removed by filtration and the filtrate was concentrated.
The residue was extracted with hexane (3*300 mL) and the combined extracts were concentrated to provide N-(3-methoxyphenyl)pivalamide in 91percent yield as a white solid.

Reference: [1] Tetrahedron, 1995, vol. 51, # 45, p. 12263 - 12276
[2] Patent: US2008/318941, 2008, A1, . Location in patent: Page/Page column 38-39
[3] Patent: WO2009/23844, 2009, A2, . Location in patent: Page/Page column 127-128
[4] Patent: US2008/200471, 2008, A1, . Location in patent: Page/Page column 60; 61
[5] Patent: US2010/16297, 2010, A1, . Location in patent: Page/Page column 35
[6] Patent: WO2010/21797, 2010, A1, . Location in patent: Page/Page column 92
[7] Patent: US2010/29629, 2010, A1, . Location in patent: Page/Page column 61
[8] Patent: WO2010/24980, 2010, A1, . Location in patent: Page/Page column 110
[9] Patent: US2010/22581, 2010, A1, . Location in patent: Page/Page column 45; 46
  • 7
  • [ 75-98-9 ]
  • [ 56619-93-3 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 18, p. 4602 - 4605
  • 8
  • [ 110-71-4 ]
  • [ 3282-30-2 ]
  • [ 56619-93-3 ]
Reference: [1] Patent: WO2005/26158, 2005, A1, . Location in patent: Page/Page column 32
  • 9
  • [ 536-90-3 ]
  • [ 1538-75-6 ]
  • [ 56619-93-3 ]
Reference: [1] Chemical Communications, 2013, vol. 49, # 40, p. 4552 - 4554
  • 10
  • [ 754-10-9 ]
  • [ 766-85-8 ]
  • [ 56619-93-3 ]
Reference: [1] Chemistry - A European Journal, 2017, vol. 23, # 55, p. 13676 - 13683
  • 11
  • [ 591-27-5 ]
  • [ 56619-93-3 ]
Reference: [1] Tetrahedron, 1995, vol. 51, # 45, p. 12263 - 12276
[2] Tetrahedron, 1995, vol. 51, # 45, p. 12263 - 12276
[3] Tetrahedron, 1995, vol. 51, # 45, p. 12263 - 12276
  • 12
  • [ 1538-75-6 ]
  • [ 56619-93-3 ]
Reference: [1] Tetrahedron, 1995, vol. 51, # 45, p. 12263 - 12276
  • 13
  • [ 138459-91-3 ]
  • [ 56619-93-3 ]
Reference: [1] Tetrahedron, 1995, vol. 51, # 45, p. 12263 - 12276
  • 14
  • [ 56619-93-3 ]
  • [ 61090-37-7 ]
Reference: [1] Patent: EP2881397, 2015, A1,
[2] Patent: US2016/303089, 2016, A1,
  • 15
  • [ 56619-93-3 ]
  • [ 100367-36-0 ]
Reference: [1] Journal of the American Chemical Society, 1995, vol. 117, # 25, p. 6666 - 6672
[2] Farmaco, 1995, vol. 50, # 6, p. 425 - 430
  • 16
  • [ 56619-93-3 ]
  • [ 108937-87-7 ]
Reference: [1] Tetrahedron Letters, 1994, vol. 35, # 40, p. 7303 - 7306
  • 17
  • [ 56619-93-3 ]
  • [ 160893-04-9 ]
Reference: [1] Patent: WO2016/34512, 2016, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 56619-93-3 ]

Aryls

Chemical Structure| 6312-87-4

[ 6312-87-4 ]

N-(4-Phenoxyphenyl)acetamide

Similarity: 0.81

Chemical Structure| 5472-37-7

[ 5472-37-7 ]

N-(2-Amino-4-methoxyphenyl)acetamide

Similarity: 0.81

Chemical Structure| 3070-86-8

[ 3070-86-8 ]

N,N'-(Oxybis(4,1-phenylene))diacetamide

Similarity: 0.81

Chemical Structure| 621-42-1

[ 621-42-1 ]

N-(3-Hydroxyphenyl)acetamide

Similarity: 0.80

Chemical Structure| 13040-21-6

[ 13040-21-6 ]

N-(3-Hydroxyphenyl)acrylamide

Similarity: 0.79

Ethers

Chemical Structure| 6312-87-4

[ 6312-87-4 ]

N-(4-Phenoxyphenyl)acetamide

Similarity: 0.81

Chemical Structure| 5472-37-7

[ 5472-37-7 ]

N-(2-Amino-4-methoxyphenyl)acetamide

Similarity: 0.81

Chemical Structure| 3070-86-8

[ 3070-86-8 ]

N,N'-(Oxybis(4,1-phenylene))diacetamide

Similarity: 0.81

Chemical Structure| 22246-17-9

[ 22246-17-9 ]

7-Methoxy-3,4-dihydroquinolin-2(1H)-one

Similarity: 0.79

Chemical Structure| 1588440-89-4

[ 1588440-89-4 ]

4-(Aminomethyl)-7-methoxy-3,4-dihydroquinolin-2(1H)-one hydrochloride

Similarity: 0.78

Amides

Chemical Structure| 6312-87-4

[ 6312-87-4 ]

N-(4-Phenoxyphenyl)acetamide

Similarity: 0.81

Chemical Structure| 5472-37-7

[ 5472-37-7 ]

N-(2-Amino-4-methoxyphenyl)acetamide

Similarity: 0.81

Chemical Structure| 3070-86-8

[ 3070-86-8 ]

N,N'-(Oxybis(4,1-phenylene))diacetamide

Similarity: 0.81

Chemical Structure| 621-42-1

[ 621-42-1 ]

N-(3-Hydroxyphenyl)acetamide

Similarity: 0.80

Chemical Structure| 4664-13-5

[ 4664-13-5 ]

4-Hydroxy-3,6-dimethylpyridin-2(1H)-one

Similarity: 0.79

Amines

Chemical Structure| 6312-87-4

[ 6312-87-4 ]

N-(4-Phenoxyphenyl)acetamide

Similarity: 0.81

Chemical Structure| 5472-37-7

[ 5472-37-7 ]

N-(2-Amino-4-methoxyphenyl)acetamide

Similarity: 0.81

Chemical Structure| 3070-86-8

[ 3070-86-8 ]

N,N'-(Oxybis(4,1-phenylene))diacetamide

Similarity: 0.81

Chemical Structure| 621-42-1

[ 621-42-1 ]

N-(3-Hydroxyphenyl)acetamide

Similarity: 0.80

Chemical Structure| 13040-21-6

[ 13040-21-6 ]

N-(3-Hydroxyphenyl)acrylamide

Similarity: 0.79